ZA855460B - Spiro-imidazolones for treatment of diabetic complications - Google Patents

Spiro-imidazolones for treatment of diabetic complications

Info

Publication number
ZA855460B
ZA855460B ZA855460A ZA855460A ZA855460B ZA 855460 B ZA855460 B ZA 855460B ZA 855460 A ZA855460 A ZA 855460A ZA 855460 A ZA855460 A ZA 855460A ZA 855460 B ZA855460 B ZA 855460B
Authority
ZA
South Africa
Prior art keywords
pct
spiro
imidazolones
treatment
diabetic complications
Prior art date
Application number
ZA855460A
Other languages
English (en)
Inventor
Christopher Andrew Lipinski
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of ZA855460B publication Critical patent/ZA855460B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/10Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
ZA855460A 1984-07-20 1985-07-19 Spiro-imidazolones for treatment of diabetic complications ZA855460B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1984/001155 WO1986000807A1 (fr) 1984-07-20 1984-07-20 Spiro-imidazolones pour le traitement des complications a la suite de diabete

Publications (1)

Publication Number Publication Date
ZA855460B true ZA855460B (en) 1987-02-25

Family

ID=22182207

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA855460A ZA855460B (en) 1984-07-20 1985-07-19 Spiro-imidazolones for treatment of diabetic complications

Country Status (19)

Country Link
US (1) US4680306A (fr)
EP (1) EP0171213B1 (fr)
KR (1) KR870000626B1 (fr)
AT (1) ATE37372T1 (fr)
AU (1) AU553719B2 (fr)
CA (1) CA1246085A (fr)
DE (1) DE3565106D1 (fr)
DK (1) DK329485A (fr)
EG (1) EG17281A (fr)
ES (1) ES8604594A1 (fr)
FI (1) FI80037C (fr)
GR (1) GR851763B (fr)
HU (1) HU198212B (fr)
IL (1) IL75801A (fr)
PH (1) PH21886A (fr)
PL (1) PL145598B1 (fr)
PT (1) PT80829B (fr)
WO (1) WO1986000807A1 (fr)
ZA (1) ZA855460B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO3501B1 (ar) * 2014-12-22 2020-07-05 Servier Lab مشتقات 5-{(بيبرازين - 1-يل)-3-أوكسو - بروبيل}- إيميدازوليدين-2، 4 - دايون كمثبطات ل adamts لمعالجة هشاشة العظام)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3985888A (en) * 1969-07-24 1976-10-12 Richardson-Merrell Inc. Methods of inducing sedation using certain spiroalkanone-imides
US3821383A (en) * 1972-07-10 1974-06-28 Ayerst Mckenna & Harrison Compositions for and a method of treating diabetic complications
US4117230A (en) * 1976-10-18 1978-09-26 Pfizer Inc. Hydantoin derivatives as therapeutic agents
US4130714A (en) * 1977-05-23 1978-12-19 Pfizer Inc. Hydantoin therapeutic agents
US4127665A (en) * 1978-01-18 1978-11-28 Pfizer Inc. Thienohydantoin derivatives
US4147797A (en) * 1978-08-11 1979-04-03 Pfizer Inc. Spiro-furanohydantoin derivatives
US4248882A (en) * 1980-02-12 1981-02-03 Pfizer Inc. Treating diabetes-associated complications with hydantoin amines
IE52879B1 (en) * 1981-05-12 1988-03-30 Ici Plc Pharmaceutical spiro-hydantoin derivatives
DE3262294D1 (en) * 1981-05-13 1985-03-28 Ici Plc Pharmaceutical compositions containing spiro succinimide derivatives
US4575507A (en) * 1985-05-29 1986-03-11 Pfizer Inc. Spiro-imidazolidines as aldose reductase inhibitors and their pharmaceutical use

Also Published As

Publication number Publication date
KR870000626B1 (ko) 1987-03-26
DK329485A (da) 1986-01-21
IL75801A (en) 1988-09-30
PL254593A1 (en) 1986-06-17
HU198212B (en) 1989-08-28
KR860001114A (ko) 1986-02-22
EP0171213B1 (fr) 1988-09-21
DK329485D0 (da) 1985-07-19
ATE37372T1 (de) 1988-10-15
FI80037B (fi) 1989-12-29
HUT39087A (en) 1986-08-28
US4680306A (en) 1987-07-14
CA1246085A (fr) 1988-12-06
DE3565106D1 (en) 1988-10-27
WO1986000807A1 (fr) 1986-02-13
AU4518985A (en) 1986-01-23
EP0171213A1 (fr) 1986-02-12
ES8604594A1 (es) 1986-02-01
ES545353A0 (es) 1986-02-01
PT80829B (pt) 1987-11-30
GR851763B (fr) 1985-11-26
FI80037C (fi) 1990-04-10
IL75801A0 (en) 1985-11-29
PH21886A (en) 1988-03-25
FI861125A0 (fi) 1986-03-18
PT80829A (en) 1985-08-01
AU553719B2 (en) 1986-07-24
FI861125A (fi) 1986-03-18
EG17281A (en) 1989-06-30
PL145598B1 (en) 1988-10-31

Similar Documents

Publication Publication Date Title
ES483511A1 (es) Un procedimiento para la preparaion de nuevas espiro-oxazo- lidinohoinas.
BR9402902A (pt) Hormônio paratiróideo e raloxifeno, compostos e formulação farmacêutica.
EP0328251A3 (en) 2-(2-hydroxy-3-phenoxypropylamino)ethylphenoxyacetamides and processes and intermediates for their preparation
ZA848369B (en) Pharmaceutical compositions containing bilobalid for the treatment of neuropathies
EP0363415A4 (en) Compounds for the treatment of alzheimer's disease
DE69027311D1 (en) Neue chroman- und thiochromanderivate
GR861803B (en) Novel carbonic acid derivatives method for their preparation their use and medicine containing them
IL72928A (en) Bronchodilating pharmaceutical compositions containing 5,6-dialkoxybenzothiophene-2-carboxylic acid
GR852979B (fr)
ZA886097B (en) Pharmaceutical composition for the treatment of psoriasis
EG17281A (en) Spiro-imidazolones for treatment of diabetes complications
IE832854L (en) Spiro-3-hetero-azolones for treatment of diabetic¹complications.
DE3467166D1 (en) Spiro-succinimides for treatment of diabetes complications
IL88726A0 (en) Dihydrothienobenzodiazepinone derivatives,pharmaceutical compositions containing the same and processes for the preparation thereof